Effect of Mediterranean Diet in Dyslipidemic Patients

Inclusion Criteria: * One or more of this criteria (total cholesterol ≥ 200mg/dl, LDL- cholesterol ≥130 mg/dL, triglyceride ≥ 200mg/dl) * If woman of child bearing potential, agree to use effective contraception throughout the study period and 30 days after discontinuation of study drug * Able to speak and read Korean * Able to comply with all required study procedures and schedule * Willing and able to give written informed consent * Participants who are not participating in other clinical trials. Exclusion Criteria: * Participants with cancer treatment * Participants with uncontrolled hypertension (systolic blood pressure (SBP) \>180 mmHg, or diastolic blood pressure (DBP) \>120 mmHg) * Participants with uncontrolled diabetes or fasting glucose ≥ 200mg/dl) * Participants with hepatic disease (aspartate aminotransferase (AST)/alanine aminotransferase (ALT) \>3 x institutional upper limit of normal) or renal disease (serum creatinine \>2.0 mg/dL) * Participants with significant cardiovascular disease (ischemic heart disease or stroke) * Participants who are taking lipid-lowering medications. * Participants who are taking other clinical trial medications. * Participants with acute infectious disease such as pneumonia, acute gastroenteritis, and urinary tract infection. * Vegetarian (does not eat red meat, poultry or fish) * Participants with food allergy (sea food, fish, nuts, egg, meat, tomato, wheat, or soybean) * Participants who are not able to eat more than 10 mediterranean meal in a row. * Any condition which in the opinion of the investigator makes the subject unsuitable for inclusion in this study